Beneficial use of steroids in hereditary neuropathy with liability to pressure palsy

    Research output: Contribution to journalArticlepeer-review

    6 Citations (Scopus)


    Management of hereditary neuropathy with liability to pressure palsy (HNPP) is primarily conservative, aimed at preventing nerve injury by avoiding trauma or other potential aggravating factors. No pharmacological treatment is known to be beneficial. We describe two adolescents, one with HNPP (male; aged 15y) and another with a clinical picture suggestive of HNPP (genetically unconfirmed; female; aged 14y), who showed considerable improvement of their symptoms after receiving corticosteroid therapy. Both individuals were symptomatic for at least 5 months before the treatment. Following corticosteroids, both individuals demonstrated rapid improvement leading to near-complete recovery of muscle power. Clinical improvement after corticosteroid therapy has been reported in some individuals with other hereditary neuropathies. Our cases demonstrate that corticosteroid therapy may also be beneficial in individuals with HNPP who have a protracted or incomplete course of recovery.

    Original languageEnglish
    Pages (from-to)183-186
    Number of pages4
    JournalDevelopmental Medicine and Child Neurology
    Issue number2
    Publication statusPublished - Feb 2012


    • TYPE-1
    • FAMILY


    Dive into the research topics of 'Beneficial use of steroids in hereditary neuropathy with liability to pressure palsy'. Together they form a unique fingerprint.

    Cite this